Adult Cognitive DiseaseThe research corpus Monographs

Epigenetic Repression

Epigenetic Repression enters the Adult Cognitive Disease corpus through the work of Varghese John (submission 78), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Varghese John's submission is summarised in this corpus as:

Apolipoprotein E4 (ApoE4), the major genetic risk factor for sporadic late-onset Alzheimer's disease, exerts a broad panoply of pro-AD effects rather than acting through a single pathway. ApoE4 shifts APP processing toward amyloidogenic cleavage (raising BACE1, lowering ADAM10/sAPPalpha), represses the longevity deacetylase Sirtuin 1 (SirT1), and drives mitochondrial dysfunction, lysosomal leakage, and tau phosphorylation. The proposal applies a systems-pharmacology drug-discovery approach to develop first-in-class, brain-permeable small molecules that target these ApoE4 mechanisms for multi-modal AD therapy.

Where it sits

The submission scores against the framework's convergence nodes as: endosomal nexus 9 · ApoE4 hub 9 · transcriptional / epigenetic 8 · cytoskeletal collapse 2 · compensatory paradigm 2 · neuroimmune interface 1.

Its declared subject matter: apoe4, systems-pharmacology, sirtuin-1, app-processing, bace1, adam10, lysosomal-dysfunction, multi-modal-therapy.

Use in the corpus

Referred to by 2 documents in the research corpus, including research/barron-synthesis/cards/yenamandra_2010_ebv_ebna3_vdr.md, research/ramsden-lipid-peroxidation/The_Bond_Not_Made.md.

Named by the same submission

7 other concepts enter the corpus through the same paper, so they cover adjacent ground: Autophagy · Endolysosomal Dysfunction · Selective Tau Disruption · Systems Biology · Tau Propagation · Tau Scaffolding Interactions · Vesicular Trafficking.

cognitive resilience · Ferroptosis · Intracellular Amyloid

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier; the reference count is measured across the research corpus. It has not yet been expanded into an article.

Last reviewed 15 August 2026.

Important noticeThis is a research platform, not a medical site. Nothing here is medical advice, a diagnosis, or a treatment recommendation, and none of it has been reviewed by a regulator. The drugs, doses and trials discussed are research literature, not prescriptions. If dementia affects you or someone you care about, speak to a doctor.

Compiled from the knowledge base and the research corpus under the Organic Network Synthesis methodology · the research corpus of Adult Cognitive Disease · the seven monographs are here. 2026.

827 interlinked articles · 120 papers in full · 53 as typeset PDFs · 635 concepts · 7 convergence nodes · 5 temporal stages.

Discussion

Corrections and disagreements are welcome here, and citation corrections most of all. Posting needs a GitHub account. Please read Taking Part first — in particular, nothing here is medical advice.